PHARAONIA Pharmaceuticals, founded in 1997, is a notable player among Egypt's top 30 pharmaceutical companies, with aspirations to break into the top 10. The company's commitment, encapsulated in its slogan "Committed to care," is demonstrated through its expansive portfolio, producing over 270 pharmaceutical brands from its substantial facility in Borg El-Arab, Alexandria.
This dynamic enterprise taps into several industries, including Biotechnology, Health Care, Manufacturing, and Pharmaceutical. In line with its growth targets, PHARAONIA Pharmaceuticals exports to more than 12 countries, showcasing its robust international reach. Recent strategic developments include the inauguration of a state-of-the-art sterile area, amplifying its production capacity and quality.
Further underscoring its growth potential, the company has bolstered its promotional capabilities by launching two new strategic units aimed at enhancing product outreach. Despite its ambitious expansion, PHARAONIA Pharmaceuticals has yet to secure external investment, presenting a ripe opportunity for potential investors seeking a foothold in a burgeoning market.